You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis

  • Technology appraisal guidance
  • Reference number: TA199
  • Published:  25 August 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive

Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive Psoriatic arthritis - etanercept, infliximab and adalimumab review proposal: Appendix B proposal paper presented to the Institute's Guidance Executive
13 June 2013
(467.84 Kb 16 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 22 August 2014

Back to top